TNFRSF9 and neoplasm: Several other agonistic antibodies targeting costimulatory molecules, such as the TNF receptor superfamily members (TNFRSF) CD137 and OX40, that are expressed on tumor-infiltrating T-cells, are currently under investigation in cancer immunotherapy46,47.